Prescription Drugs

Filters

Online Exclusive

SALE UP TO 25% OFF

Shop The Sale

Ibtrozi (Taletrectinib) 200mg Capsules | ROS1 Inhibitor | GLT

Nuvation Bio next-generation ROS1 inhibitor for ROS1-positive NSCLC

Vijoice (Alpelisib) 50mg/125mg/200mg Tablets | FDA-Approved PROS Therapy | GLT

Vijoice by Novartis — the first and only FDA-approved treatment for PIK3CA-Related Overgrowth Spectrum (PROS),...

Mounjaro 穆峰达 (Tirzepatide) 2.5–10mg/0.5mL Multi-Dose Pen | Eli Lilly China | GLT

Mounjaro (穆峰达) — the originator tirzepatide by Eli Lilly, China Mainland four-strength multi-dose pen (2.5/5/7.5/10mg)...
Sold Out

Ceritinib (Spexib) 150mg*150's | Novartis India Originator | GLT

Novartis's Indian-market ceritinib (Spexib) 150mg capsules, 150 per multipack for ALK-positive NSCLC — same originator...
Sold Out

Tagrisso (Osimertinib) 80mg*30 | AstraZeneca UK Originator | GLT

AstraZeneca UK originator osimertinib 80mg — the reference EGFR TKI for NSCLC
Sold Out

Tagrisso (Osimertinib) 80mg*30 | AstraZeneca China NMPA | GLT

China-Mainland Tagrisso 80mg — NMPA-approved, nationally reimbursed originator osimertinib
Sold Out

Ceritinib (Zykadia) 150mg*10's | Novartis Switzerland Originator | GLT

Novartis Switzerland originator Zykadia (ceritinib) 150mg capsules, 10-capsule starter pack for ALK-positive NSCLC.
Sold Out

Sumeirui (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Nanjing Youke Pharmaceutical Co., Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Nanjing Youke Pharmaceutical Co., Ltd. (China-Mainland) — an affordable alternative...
Sold Out

Ceritinib (Zykadia) 150mg*150's | Novartis China-Sourced | GLT

Novartis China-sourced Zykadia (ceritinib) 150mg capsules, NMPA-approved & reimbursed for ALK-positive NSCLC.
Sold Out

Ceritinib (Noxalk) 150mg*90's | Natco India Generic | GLT

Noxalk — Natco Pharma India generic ceritinib 150mg, 90-capsule pack for ALK-positive NSCLC.
Sold Out

Tepmetko (Tepotinib) 225mg*60 | Merck KGaA Germany Originator | GLT

Merck KGaA Germany originator tepotinib 225mg — the first oral MET inhibitor for NSCLC
Sold Out

Tepmetko (Tepotinib) 225mg*60 | Merck KGaA China NMPA | GLT

China-Mainland Tepmetko 225mg — NMPA-approved, nationally reimbursed originator tepotinib
Sold Out

Vitrakvi (Larotrectinib) 100mg×60 Capsules | Bayer US NTRK Fusion | GLT

Vitrakvi — Bayer originator larotrectinib (Loxo Oncology), US pack 100mg×60-capsule bottle (NDC 71777-391-01) for NTRK...
Sold Out

Vitrakvi (Larotrectinib) 100mg×56 Capsules | Bayer China 维泰凯 NTRK Fusion | GLT

Vitrakvi 维泰凯 — Bayer originator larotrectinib, 100mg×56-capsule bottle (国药准字 HJ20220033) for NTRK fusion-positive solid tumors,...
Sold Out

Alunbrig (Brigatinib) 30mg/90mg/180mg*28's | China-Sourced ALK Inhibitor | GLT

Takeda brigatinib, NMPA-approved and reimbursed in China-Mainland
Sold Out

PHOBRIGA (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

Lao generic brigatinib by Pharma 2 Vientiane, affordable ALK+ NSCLC therapy
Sold Out

Saibriga (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

Lao generic brigatinib by BioSpring, affordable ALK+ NSCLC therapy
Sort
  • Recommended
  • Price: Low to High
  • Price: High to Low
  • Newest
  • Best Selling